Skip to main content
Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
1.378
+0.010 (0.73%)
Mar 9, 2026, 5:35 PM CET

Vivoryon Therapeutics Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
40.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023-3.62M--
Dec 31, 2022---
Dec 31, 202110.76M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ctac N.V. 125.22M
Bever Holding NV 2.00K
Cabka 185.20M
Morefield Group 101.04M
BM3EAC 340.60K
Ebusco Holding 848.00K
Value8 8.16M
Alumexx 39.87M
Revenue Rankings

Vivoryon Therapeutics News

More News